Inclusion Criteria:  Genetically confirmed spinal muscular atrophy. Treatment by Spinraza ° or by risdiplam planned. Over 6 years old. Signed informed consent.  Exclusion Criteria:  - Patients with excessive cognitive disorders, limiting the understanding of task or with apparent communication difficulties hindering data collection.